ImmuniWeb vs. Metasploit
ImmuniWeb vs. Metasploit
Product | Rating | Most Used By | Product Summary | Starting Price |
---|---|---|---|---|
ImmuniWeb | N/A | ImmuniWeb® AI Platform illuminates the user's external attack surface and Dark Web exposure, designed to provide well-informed, risk-based and DevSecOps-enabled application penetration testing. ImmuniWeb helps users to achieve: - Holistic visibility of digital assets and risks - Risk-based and threat-aware testing - Full DevSecOps & CI/CD integration | N/A | |
Metasploit | N/A | Metasploit is open source network security software described by Rapid7 as the world’s most used penetration testing framework, designed to help security teams do more than just verify vulnerabilities, manage security assessments, and improve security awareness. | N/A |
ImmuniWeb | Metasploit | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Editions & Modules | No answers on this topic | No answers on this topic | ||||||||||||||
Offerings |
| |||||||||||||||
Entry-level Setup Fee | No setup fee | No setup fee | ||||||||||||||
Additional Details | — | — | ||||||||||||||
More Pricing Information |
ImmuniWeb | Metasploit | |
---|---|---|
Top Pros | No answers on this topic | |
Top Cons | No answers on this topic |
|
ImmuniWeb | Metasploit | |
---|---|---|
Small Businesses | GitLab Score 8.9 out of 10 | No answers on this topic |
Medium-sized Companies | GitLab Score 8.9 out of 10 | Veracode Score 8.5 out of 10 |
Enterprises | GitLab Score 8.9 out of 10 | Veracode Score 8.5 out of 10 |
All Alternatives | View all alternatives | View all alternatives |
ImmuniWeb | Metasploit | |
---|---|---|
Likelihood to Recommend | - (0 ratings) | 10.0 (6 ratings) |
Support Rating | - (0 ratings) | 7.0 (1 ratings) |
ImmuniWeb | Metasploit | |
---|---|---|
Likelihood to Recommend | ImmuniWeb No answers on this topic | Rapid7 |
Pros | ImmuniWeb No answers on this topic | Rapid7 |
Cons | ImmuniWeb No answers on this topic | Rapid7 |
Support Rating | ImmuniWeb No answers on this topic | Rapid7 |
Alternatives Considered | ImmuniWeb No answers on this topic | Rapid7 |
Return on Investment | ImmuniWeb No answers on this topic | Rapid7 |
ScreenShots | ImmuniWeb Screenshots |